Reuters logo
BRIEF-CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba
October 19, 2016 / 10:35 PM / a year ago

BRIEF-CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba

Oct 19 (Reuters) - Pfizer Inc :

* CDC Advisory Committee on Immunization Practices votes to recommend new dosing schedule for vaccination with trumenba (meningococcal Group B vaccine)

* CDC’s ACIP voted to recommend for persons at increased risk for meningococcal disease, 3 doses of trumenba should be administered at 0, 1-2,6 months

* CDC’s ACIP voted to recommend for use during serogroup B outbreaks, 3 doses of trumenba should be administered at 0, 1-2, and 6 months

* CDC’s ACIP voted to recommend when given to minors not at increased risk for meningococcal disease, 2 doses of trumenba to be given at 0,6 months Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below